Moderna rallies 12% to set new high (MRNA:NASDAQ)
· seekingalpha.com
Moderna (MRNA) hits a new 52-week high on ESMO 2026 oncology data plans as intismeran buzz grows.
Moderna (MRNA) shares climbed just over 12% on Monday, continuing their recent volatile trading to set a fresh 52-week high. The stock closed at $172.94, rising...